RegeneCure Ltd.
http://www.regenecure.co.il
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From RegeneCure Ltd.
Start-Up Quarterly Statistics, Q1 2011
Biopharma and medical device start-ups brought in a total of $216 million in Q1 2011. Absent were any financings involving in vitro diagnostics companies. Only four acquisitions involving start-ups were completed - one in biopharma and three in the device industry. Cancer was the most popular therapeutic category among biopharma start-up alliance this quarter.
Recent Tech Transfer Deals (04/11)
Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.
Deals Update
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Selected Start-Ups (03/2011)
In Vivo briefly describes these recently founded companies: 2C Tech Corp., Atherolysis Medical, Axena Technologies, Diartis Pharmaceuticals, Prevention Pharmaceuticals and RegeneCure.
Company Information
- Industry
- Biotechnology
-
Medical Devices
- Biomaterials
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice